Exome Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Hold	0	–	–	–	68
2024 Q2	–	Sell	-17,800	Closed	-$831K	–	67
2024 Q1	$831K	Buy	+17,800	New	+$831K	0.71%	48